GSK-3326595 |
GSK-3326595 |
1616392-22-3 |
XY1 |
N-2-萘基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 |
1624117-53-8 |
WZB117 |
WZB-117 |
1223397-11-2 |
RGFP 109 |
RG2833(RGFP109) |
1215493-56-3 |
HSF1A |
HSF1 ACTIVATOR;HSF1A;CAS 1196723-93-9 |
1196723-93-9 |
(1-(2,2,2-trifluoroethyl)-1H-pyrazol-5-yl) |
(1-(2,2,2-三氟乙基)-1H-吡唑-5-基)甲醇 |
1296225-26-7 |
3-(Phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]-4(3H)-quinazolinone |
RAD51 INHIBITOR B02 |
1290541-46-6 |
7-(5-(1,5-dichloropentan-3-yl)-1-Methyl-1H-benzo[d]iMidazol-2-yl)-N-hydroxyheptanaMide |
EDO-S101 |
1236199-60-2 |
(R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDINE HYDROCHLORIDE |
(R)-2-(2,5-二氟苯基)吡咯烷盐酸盐 |
1218935-60-4 |
3-(5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzoicacid |
3-(5-(三氟甲基)-1,2,4-恶二唑-3-基)苯甲酸 |
1092400-82-2 |
N-(5-bromo-2-methoxypyridin-3-yl)-2,4-difluorobenzenesulfonamide |
N-(5-溴-2-甲氧基吡啶-3-基)-2,4-二氟苯磺酰胺 |
1086063-46-8 |
(R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid |
艾沙佐米 |
1072833-77-2 |
5 - fluoro - 2 - (4 - Methoxy phenyl) (acetylene) benzaldehyde |
5-氟-2 -((4-甲氧基苯基)乙炔基)苯甲醛 |
1042369-35-6 |
5-(hydroxyMethyl)-4-Methyl-2H-1,2,4-triazol-3(4H)-one |
5-(HYDROXYMETHYL)-4-METHYL-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE |
1182358-83-3 |
Lusutrombopag |
鲁索曲波帕 |
1110766-97-6 |
1-(Methylnitrosoamino)-2-propanol |
MHP |
1104874-94-3 |
3-(Methylsulfonyl)phenylboronic Acid Pinacol Ester |
3-甲砜基苯硼酸频哪醇酯 |
1001185-88-1 |
PD168393 |
PD168393 |
194423-15-9 |
6-FLUOROBENZO[C][1,2]OXABOROL-1(3H)-OL |
2-羟基甲基-6-氟苯硼酸半酯 |
174671-89-7 |
(E)-4-[2-{2-[N-(4-Methoxybenzenesulfonyl)aMino]phenyl}ethenyl ]pyridine |
173528-92-2 |
173528-92-2 |